Robeco Schweiz’s Usana Health Sciences USNA Stock Holding History

Robeco Schweiz’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,466	Closed	-$126K	–	188
2018 Q1	$126K	Buy	+1,466	New	+$114K	0.01%	161

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Robeco Schweiz's USNA Position: Q2 2018 in Review

Robeco Schweiz sold out of Usana Health Sciences (USNA) in Q2 2018, closing a stake of 1,466 shares — an estimated $126K sold.

Robeco Schweiz first reported a position in USNA in Q1 2018 and held it in 1 quarter. The position peaked at $126K in Q1 2018. 189 funds tracked by Wall St. Rank hold USNA as of Q2 2018.

Robeco Schweiz reported no remaining Usana Health Sciences position as of Q2 2018 after selling out during the quarter.
Robeco Schweiz sold 1,466 Usana Health Sciences shares in Q2 2018, an estimated $126K.
Robeco Schweiz first reported a position in Usana Health Sciences in Q1 2018 and held it in 1 quarter.
Robeco Schweiz's Usana Health Sciences position peaked at $126K in Q1 2018.
189 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2018.

Based on Robeco Schweiz's 13F filing for Q2 2018, filed 9 Aug 2018.